Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Humulin-R for Hypoglycemia Awareness in Type 1 Diabetes
NCT04028960Phase 2Terminated
- Sponsor
- HealthPartners Institute
- Start
- Oct 2019
- Primary completion
- Apr 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of intranasal insulin in type 1 diabetes mellitus (T1D), sponsored by HealthPartners Institute. Started Oct 2019; status: terminated.
02
Drugs
intranasal insulin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT04028960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04028960.